Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.3653
+0.0051 (1.42%)
Aug 28, 2026, 2:25 PM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $2.03 million as of August 28, 2026. Its market cap has decreased by -51.72% in one year.
Market Cap
2.03M
Enterprise Value
1.21M
1-Year Change
-51.72%
Ranking
Category
Stock Price
$0.37
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $2.03M, a decrease of -98.63%. That is a compound annual growth rate of -54.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.03M | -66.17% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 3.22M |
| Matinas BioPharma Holdings | 2.89M |
| Clearmind Medicine | 2.56M |
| Onconetix | 2.53M |
| Propanc Biopharma | 2.44M |
| Oragenics | 2.39M |
| Virax Biolabs Group | 2.21M |
| Decoy Therapeutics | 1.97M |